Ondine Biomedical Inc. (AIM:OBI)
London flag London · Delayed Price · Currency is GBP · Price in GBX
13.75
0.00 (0.00%)
Oct 10, 2025, 3:49 PM GMT+1

Ondine Biomedical Income Statement

Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
2.22.051.20.642.571.79
Upgrade
Revenue Growth (YoY)
34.82%70.32%88.56%-75.17%43.44%16.84%
Upgrade
Cost of Revenue
0.750.730.50.351.321.14
Upgrade
Gross Profit
1.451.320.70.291.250.65
Upgrade
Selling, General & Admin
11.1611.019.812.3113.3312.04
Upgrade
Research & Development
13.889.225.146.284.983.31
Upgrade
Operating Expenses
25.5820.7715.5119.0518.7716.52
Upgrade
Operating Income
-24.13-19.44-14.81-18.76-17.52-15.87
Upgrade
Interest Expense
-0.01-0.03-0.05-0.03-0.01-0.49
Upgrade
Interest & Investment Income
0.220.030.240.19--
Upgrade
Currency Exchange Gain (Loss)
-0.170.04-0.140.640.190.14
Upgrade
Other Non Operating Income (Expenses)
0.210.30-1.33-1.63-0.05
Upgrade
EBT Excluding Unusual Items
-23.9-19.1-14.75-19.29-18.98-16.27
Upgrade
Gain (Loss) on Sale of Assets
---0.1-0.08--
Upgrade
Other Unusual Items
--0.44--31.11-
Upgrade
Pretax Income
-23.9-19.1-14.41-19.37-50.09-16.27
Upgrade
Net Income
-23.9-19.1-14.41-19.37-50.09-16.27
Upgrade
Net Income to Common
-23.9-19.1-14.41-19.37-50.09-16.27
Upgrade
Shares Outstanding (Basic)
3722751971958071
Upgrade
Shares Outstanding (Diluted)
3722751971958071
Upgrade
Shares Change (YoY)
68.94%39.31%1.30%144.34%12.69%761.95%
Upgrade
EPS (Basic)
-0.06-0.07-0.07-0.10-0.63-0.23
Upgrade
EPS (Diluted)
-0.06-0.07-0.07-0.10-0.63-0.23
Upgrade
Free Cash Flow
-18.61-15.5-13.83-16.66-12.62-6.36
Upgrade
Free Cash Flow Per Share
-0.05-0.06-0.07-0.09-0.16-0.09
Upgrade
Gross Margin
65.77%64.47%58.44%44.98%48.81%36.24%
Upgrade
Operating Margin
-1095.51%-948.95%-1230.67%-2940.91%-681.98%-886.15%
Upgrade
Profit Margin
-1084.66%-932.06%-1198.01%-3036.36%-1949.59%-908.49%
Upgrade
Free Cash Flow Margin
-844.53%-756.47%-1149.63%-2610.66%-491.13%-355.00%
Upgrade
EBITDA
-23.71-19.24-14.59-18.54-17.24-14.91
Upgrade
D&A For EBITDA
0.420.210.210.220.280.96
Upgrade
EBIT
-24.13-19.44-14.81-18.76-17.52-15.87
Upgrade
Advertising Expenses
-0.130.180.230.14-
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.